Author/Authors :
Kumar, Santosh Department of Urology - Post Graduate Institute of Medical Education and Research - Chandigarh, India , Jayant, Kumar Department of Urology - Post Graduate Institute of Medical Education and Research - Chandigarh, India , Prasad, Seema Department of Urology - Post Graduate Institute of Medical Education and Research - Chandigarh, India , Agrawal, Swati Department of Obstetrics and Gynaecology - Post Graduate Institute of Medical Education and Research - Chandigarh, India , Parma, Kalpesh Mahesh Department of Urology - Post Graduate Institute of Medical Education and Research - Chandigarh, India , Roat, Rajesh Department of Urology - Post Graduate Institute of Medical Education and Research - Chandigarh, India , Kumar, Kushal Department of Urology - Post Graduate Institute of Medical Education and Research - Chandigarh, India
Abstract :
Introduction: Adrenal Myelolipoma is a rare benign neoplasm, which contains mature adipose tissue and variable amounts of
haematopoietic elements. Most lesions are small and asymptomatic, discovered incidentally during autopsy or imaging studies
performed for other reasons. Case Presentation: Here we reported a series of two cases of giant myelolipomas of the adrenal gland; first one the largest tumor
reported so far presented with massive hemorrhage and the second case introduced with its rare unreported presentation of
adrenal myelolipomas i.e. a large abscess. Discussion: Adrenal myelolipoma is a rare and asymptomatic tumor usually discovered incidentally in less than 1% of population
on autopsy or imaging performed for other reasons. There is an increasing incidence of large adrenal myelolipoma (> 10 cm)
presenting with life threatening and recurrent retroperitoneal hemorrhage along with other complications as abscess. To avoid
such a life-threatening situation, authors recommend close monitoring and consideration of urgent surgical intervention for
tumors larger than 4 cm at presentation or increase in size or change in appearance during follow-up.